Evidence map›Paper›PMID 31823895›Full record

ArticleNeural regeneration research2020

Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats.

Sidharth Mehan, Saloni Rahi, Aarti Tiwari, Tarun Kapoor, Kajal Rajdev, Ramit Sharma, Himanshi Khera, Sourabh Kosey, Umesh Kukkar, Rajesh Dudi

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Plant-mediated green synthesis of gold nanoparticles using an aqueous extract ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sidharth MehanDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Saloni RahiDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Aarti TiwariDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Tarun KapoorDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Kajal RajdevDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Ramit SharmaDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Himanshi KheraDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Sourabh KoseyDepartment of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India.
Umesh KukkarDepartment of Pharmacology, Rajendra Institute of Technology & Sciences, Sirsa, Haryana, India.
Rajesh DudiPharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Indo Soviet Friendship College of Pharmacy · INIndian Institute of Integrative Medicine · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal mitochondrial dysfunction increases inflammatory mediators and leads to free radical generation and anti-oxidant enzymatic alterations, which are major neuropathological hallmarks responsible for autism. Mitochondrial dysfunction in autism is associated with decreased ATP levels due to reduced levels of cyclic adenosine monophosphate. Rat models of autism were established by intracerebroventricular injection of propionic acid. These rat models had memory dysfunction, decreased muscle coordination and gait imbalance. Biochemical estimation of propionic acid-treated rats showed changes in enzyme activity in neuronal mitochondrial electron transport chain complexes and increases in pro-inflammatory cytokines, oxidative stress and lipid biomarkers. Oral administration of 10, 20 and 30 mg/kg adenylate cyclase activator forskolin for 15 days reversed these changes in a dose-dependent manner. These findings suggest that forskolin can alleviate neuronal mitochondrial dysfunction and improve neurological symptoms of rats with autism. This study was approved by the RITS/IAEC, SIRSA, HARYANA on March 3, 2014 (approval No. RITS/IAEC/2014/03/03).

Indexed as

adenylate cyclaseATPautismforskolinmitochondrial dysfunctionneuroinflammationoxidative stresspropionic acid

Identifiers

PMID31823895
PMCPMC7034277
OpenAlexW2995995597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.